High-risk prostate cancer

Extended Follow-up from the Stereotactic Body Radiotherapy for High-risk Localized Carcinoma of the Prostate (SHARP) Consortium: Updated Analysis of 440 Patients

Valle LF, Romero-Kalbasi T, Jiang T, van Dams R, Fuller DB, Loblaw A, Kennedy T, Collins SP, Sharma V, Suy S, Murthy V, Mallick I,[...]

By afschroeder • April 13, 2026

Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography

Smith CP, Proudfoot JA, Boutros PC, Reiter RE, Valle L, Rettig MB, Nickols NG, Feng FY, Nguyen PL, Nagar H, Spratt DE, Attard G, Weiner[...]

By sjmartinez • March 5, 2023